| 111.34 Delayed Data As of Jun 26 |  -4.02 / -3.48%Today’s Change | 84.64 Today|||52-Week Range 132.13 | -3.78% Year-to-Date |
| Axsome Initiates Phase III Study on Depression Candidate Jun 25 / Zacks.comZAK - Paid Partner Content | Opinion: Medical Marijuana Is a Terrible Investment Jun 20 / MotleyFool.comFOO - Paid Partner Content |
| The 10 Biggest Biotech Stocks Jun 25 / MotleyFool.comFOO - Paid Partner Content | Lilly Declares Third-Quarter 2019 Dividend Jun 19 / PR NewswirePRN - Paid Partner Content |
| Why These Innovative Biotech ETFs Soaring Jun 24 / Zacks.comZAK - Paid Partner Content | Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio Jun 18 / Zacks.comZAK - Paid Partner Content |
| 3 Drugs Under FDA Review With Blockbuster Potential Jun 20 / MotleyFool.comFOO - Paid Partner Content | Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients Jun 18 / Zacks.comZAK - Paid Partner Content |
| Allergan Up As Analyst Statement Sparks Business Split Rumors Jun 20 / Zacks.comZAK - Paid Partner Content | Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon Jun 17 / MotleyFool.comFOO - Paid Partner Content |
| Previous close | 115.36 |
| Today’s open | 114.81 |
| Day’s range | 110.62 - 114.95 |
| Volume | 4,677,503 |
| Average volume (3 months) | 12,459,727 |
| Market cap | $112.1B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +1.49% |
| Earnings growth (next 5 years) | +9.17% |
| Revenue growth (last year) | +7.36% |
| P/E ratio | 43.0 |
| Price/Sales | 4.87 |
| Price/Book | 12.42 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | -0.34 | -0.78% |
| AZNAstraZeneca | -0.43 | -1.04% |
| ABBVAbbVie | +2.30 | +3.50% |
| GSKGlaxoSmithKline | -0.50 | -1.23% |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $1.44 |
| Annual revenue (last year) | $24.6B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 13.16% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer David A. Ricks |
Senior VP & President-Manufacturing Operations Myles Oneill |
Corporate headquarters Indianapolis, Indiana |
